nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Meningism—Methotrexate—muscle cancer	0.0522	0.0546	CcSEcCtD
Procaine—Arachnoiditis—Methotrexate—muscle cancer	0.0495	0.0518	CcSEcCtD
Procaine—Eruption—Dactinomycin—muscle cancer	0.0339	0.0355	CcSEcCtD
Procaine—Nephropathy—Etoposide—muscle cancer	0.0317	0.0332	CcSEcCtD
Procaine—Paralysis—Vincristine—muscle cancer	0.0268	0.0281	CcSEcCtD
Procaine—Nephropathy—Methotrexate—muscle cancer	0.019	0.0199	CcSEcCtD
Procaine—BCHE—diaphragm—muscle cancer	0.0185	0.423	CbGeAlD
Procaine—Apnoea—Etoposide—muscle cancer	0.0178	0.0186	CcSEcCtD
Procaine—Neuropathy—Vincristine—muscle cancer	0.0175	0.0183	CcSEcCtD
Procaine—Eruption—Methotrexate—muscle cancer	0.0147	0.0154	CcSEcCtD
Procaine—Neuropathy—Etoposide—muscle cancer	0.0142	0.0148	CcSEcCtD
Procaine—Paralysis—Methotrexate—muscle cancer	0.013	0.0136	CcSEcCtD
Procaine—Cardiac arrest—Vincristine—muscle cancer	0.0129	0.0135	CcSEcCtD
Procaine—Eruption—Doxorubicin—muscle cancer	0.0127	0.0133	CcSEcCtD
Procaine—Anaphylactoid reaction—Etoposide—muscle cancer	0.0113	0.0118	CcSEcCtD
Procaine—Paralysis—Doxorubicin—muscle cancer	0.0113	0.0118	CcSEcCtD
Procaine—Apnoea—Methotrexate—muscle cancer	0.0107	0.0112	CcSEcCtD
Procaine—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.0106	0.0111	CcSEcCtD
Procaine—Cardiac arrest—Etoposide—muscle cancer	0.0104	0.0109	CcSEcCtD
Procaine—Neuropathy peripheral—Vincristine—muscle cancer	0.0102	0.0107	CcSEcCtD
Procaine—Chills—Dactinomycin—muscle cancer	0.0094	0.00983	CcSEcCtD
Procaine—Hallucination—Vincristine—muscle cancer	0.00932	0.00974	CcSEcCtD
Procaine—Sweating increased—Etoposide—muscle cancer	0.00923	0.00965	CcSEcCtD
Procaine—Erythema—Dactinomycin—muscle cancer	0.00912	0.00954	CcSEcCtD
Procaine—Vasodilation—Doxorubicin—muscle cancer	0.00892	0.00932	CcSEcCtD
Procaine—Vasodilation procedure—Doxorubicin—muscle cancer	0.00892	0.00932	CcSEcCtD
Procaine—Neuropathy peripheral—Etoposide—muscle cancer	0.00828	0.00866	CcSEcCtD
Procaine—Leukopenia—Dactinomycin—muscle cancer	0.00817	0.00854	CcSEcCtD
Procaine—Atrioventricular block—Doxorubicin—muscle cancer	0.00808	0.00845	CcSEcCtD
Procaine—Agitation—Vincristine—muscle cancer	0.00749	0.00783	CcSEcCtD
Procaine—Oedema—Dactinomycin—muscle cancer	0.00745	0.00779	CcSEcCtD
Procaine—Neuropathy—Doxorubicin—muscle cancer	0.00736	0.00769	CcSEcCtD
Procaine—Leukopenia—Vincristine—muscle cancer	0.0073	0.00763	CcSEcCtD
Procaine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00729	0.00762	CcSEcCtD
Procaine—Convulsion—Vincristine—muscle cancer	0.00706	0.00739	CcSEcCtD
Procaine—Hypertension—Vincristine—muscle cancer	0.00704	0.00736	CcSEcCtD
Procaine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00696	0.00728	CcSEcCtD
Procaine—Chills—Etoposide—muscle cancer	0.00681	0.00712	CcSEcCtD
Procaine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00679	0.0071	CcSEcCtD
Procaine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00678	0.00709	CcSEcCtD
Procaine—Oedema—Vincristine—muscle cancer	0.00665	0.00696	CcSEcCtD
Procaine—Anaphylactic shock—Vincristine—muscle cancer	0.00665	0.00696	CcSEcCtD
Procaine—Thrombocytopenia—Vincristine—muscle cancer	0.00651	0.00681	CcSEcCtD
Procaine—Hyperhidrosis—Vincristine—muscle cancer	0.00643	0.00673	CcSEcCtD
Procaine—Fatigue—Dactinomycin—muscle cancer	0.00642	0.00671	CcSEcCtD
Procaine—Hypotension—Vincristine—muscle cancer	0.00622	0.0065	CcSEcCtD
Procaine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00606	0.00634	CcSEcCtD
Procaine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00603	0.0063	CcSEcCtD
Procaine—Leukopenia—Etoposide—muscle cancer	0.00591	0.00618	CcSEcCtD
Procaine—Body temperature increased—Dactinomycin—muscle cancer	0.00589	0.00616	CcSEcCtD
Procaine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00588	0.00614	CcSEcCtD
Procaine—Loss of consciousness—Etoposide—muscle cancer	0.0058	0.00607	CcSEcCtD
Procaine—Fatigue—Vincristine—muscle cancer	0.00574	0.006	CcSEcCtD
Procaine—Convulsion—Etoposide—muscle cancer	0.00572	0.00598	CcSEcCtD
Procaine—Hypertension—Etoposide—muscle cancer	0.0057	0.00596	CcSEcCtD
Procaine—Eosinophilia—Methotrexate—muscle cancer	0.00562	0.00588	CcSEcCtD
Procaine—Hypersensitivity—Dactinomycin—muscle cancer	0.00549	0.00574	CcSEcCtD
Procaine—Cardiac arrest—Doxorubicin—muscle cancer	0.00541	0.00566	CcSEcCtD
Procaine—Anaphylactic shock—Etoposide—muscle cancer	0.00539	0.00564	CcSEcCtD
Procaine—Thrombocytopenia—Etoposide—muscle cancer	0.00528	0.00552	CcSEcCtD
Procaine—Tachycardia—Etoposide—muscle cancer	0.00526	0.0055	CcSEcCtD
Procaine—Body temperature increased—Vincristine—muscle cancer	0.00526	0.0055	CcSEcCtD
Procaine—Hyperhidrosis—Etoposide—muscle cancer	0.00521	0.00545	CcSEcCtD
Procaine—Diarrhoea—Dactinomycin—muscle cancer	0.00509	0.00533	CcSEcCtD
Procaine—Drowsiness—Methotrexate—muscle cancer	0.00506	0.00529	CcSEcCtD
Procaine—Hypotension—Etoposide—muscle cancer	0.00504	0.00527	CcSEcCtD
Procaine—Hypersensitivity—Vincristine—muscle cancer	0.0049	0.00513	CcSEcCtD
Procaine—Eosinophilia—Doxorubicin—muscle cancer	0.00487	0.00509	CcSEcCtD
Procaine—Somnolence—Etoposide—muscle cancer	0.00479	0.00501	CcSEcCtD
Procaine—Vomiting—Dactinomycin—muscle cancer	0.00473	0.00495	CcSEcCtD
Procaine—Rash—Dactinomycin—muscle cancer	0.0047	0.00491	CcSEcCtD
Procaine—Fatigue—Etoposide—muscle cancer	0.00465	0.00486	CcSEcCtD
Procaine—Diarrhoea—Vincristine—muscle cancer	0.00455	0.00476	CcSEcCtD
Procaine—Nausea—Dactinomycin—muscle cancer	0.00442	0.00463	CcSEcCtD
Procaine—Dizziness—Vincristine—muscle cancer	0.0044	0.0046	CcSEcCtD
Procaine—Drowsiness—Doxorubicin—muscle cancer	0.00438	0.00458	CcSEcCtD
Procaine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.0043	0.00449	CcSEcCtD
Procaine—Urticaria—Etoposide—muscle cancer	0.00428	0.00448	CcSEcCtD
Procaine—Body temperature increased—Etoposide—muscle cancer	0.00426	0.00446	CcSEcCtD
Procaine—Tinnitus—Methotrexate—muscle cancer	0.00424	0.00443	CcSEcCtD
Procaine—Vomiting—Vincristine—muscle cancer	0.00423	0.00442	CcSEcCtD
Procaine—Rash—Vincristine—muscle cancer	0.00419	0.00439	CcSEcCtD
Procaine—Dermatitis—Vincristine—muscle cancer	0.00419	0.00438	CcSEcCtD
Procaine—Chills—Methotrexate—muscle cancer	0.00408	0.00426	CcSEcCtD
Procaine—Bradycardia—Doxorubicin—muscle cancer	0.00401	0.00419	CcSEcCtD
Procaine—Hypersensitivity—Etoposide—muscle cancer	0.00397	0.00415	CcSEcCtD
Procaine—Erythema—Methotrexate—muscle cancer	0.00396	0.00414	CcSEcCtD
Procaine—Nausea—Vincristine—muscle cancer	0.00395	0.00413	CcSEcCtD
Procaine—Pruritus—Etoposide—muscle cancer	0.00381	0.00399	CcSEcCtD
Procaine—GRIN3A—head—muscle cancer	0.00376	0.0861	CbGeAlD
Procaine—Vision blurred—Methotrexate—muscle cancer	0.00373	0.0039	CcSEcCtD
Procaine—Diarrhoea—Etoposide—muscle cancer	0.00369	0.00386	CcSEcCtD
Procaine—Tinnitus—Doxorubicin—muscle cancer	0.00367	0.00384	CcSEcCtD
Procaine—GRIN3A—testis—muscle cancer	0.00364	0.0832	CbGeAlD
Procaine—Dizziness—Etoposide—muscle cancer	0.00356	0.00373	CcSEcCtD
Procaine—Leukopenia—Methotrexate—muscle cancer	0.00354	0.0037	CcSEcCtD
Procaine—Chills—Doxorubicin—muscle cancer	0.00353	0.00369	CcSEcCtD
Procaine—Convulsion—Methotrexate—muscle cancer	0.00343	0.00358	CcSEcCtD
Procaine—Vomiting—Etoposide—muscle cancer	0.00343	0.00358	CcSEcCtD
Procaine—Erythema—Doxorubicin—muscle cancer	0.00342	0.00358	CcSEcCtD
Procaine—Rash—Etoposide—muscle cancer	0.0034	0.00355	CcSEcCtD
Procaine—Dermatitis—Etoposide—muscle cancer	0.00339	0.00355	CcSEcCtD
Procaine—Arthralgia—Methotrexate—muscle cancer	0.00337	0.00352	CcSEcCtD
Procaine—Tension—Doxorubicin—muscle cancer	0.00336	0.00351	CcSEcCtD
Procaine—Nervousness—Doxorubicin—muscle cancer	0.00333	0.00348	CcSEcCtD
Procaine—Anaphylactic shock—Methotrexate—muscle cancer	0.00323	0.00338	CcSEcCtD
Procaine—Vision blurred—Doxorubicin—muscle cancer	0.00323	0.00338	CcSEcCtD
Procaine—Nausea—Etoposide—muscle cancer	0.0032	0.00335	CcSEcCtD
Procaine—Thrombocytopenia—Methotrexate—muscle cancer	0.00316	0.00331	CcSEcCtD
Procaine—Agitation—Doxorubicin—muscle cancer	0.00315	0.00329	CcSEcCtD
Procaine—Hyperhidrosis—Methotrexate—muscle cancer	0.00312	0.00326	CcSEcCtD
Procaine—Syncope—Doxorubicin—muscle cancer	0.00307	0.00321	CcSEcCtD
Procaine—Leukopenia—Doxorubicin—muscle cancer	0.00307	0.00321	CcSEcCtD
Procaine—Hypotension—Methotrexate—muscle cancer	0.00302	0.00315	CcSEcCtD
Procaine—Loss of consciousness—Doxorubicin—muscle cancer	0.00301	0.00315	CcSEcCtD
Procaine—Convulsion—Doxorubicin—muscle cancer	0.00297	0.0031	CcSEcCtD
Procaine—Hypertension—Doxorubicin—muscle cancer	0.00296	0.00309	CcSEcCtD
Procaine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00294	0.00308	CcSEcCtD
Procaine—Arthralgia—Doxorubicin—muscle cancer	0.00292	0.00305	CcSEcCtD
Procaine—Anxiety—Doxorubicin—muscle cancer	0.00291	0.00304	CcSEcCtD
Procaine—Somnolence—Methotrexate—muscle cancer	0.00287	0.003	CcSEcCtD
Procaine—Oedema—Doxorubicin—muscle cancer	0.0028	0.00292	CcSEcCtD
Procaine—Anaphylactic shock—Doxorubicin—muscle cancer	0.0028	0.00292	CcSEcCtD
Procaine—Fatigue—Methotrexate—muscle cancer	0.00278	0.00291	CcSEcCtD
Procaine—CHRNA2—head—muscle cancer	0.00276	0.0632	CbGeAlD
Procaine—Shock—Doxorubicin—muscle cancer	0.00275	0.00288	CcSEcCtD
Procaine—Thrombocytopenia—Doxorubicin—muscle cancer	0.00274	0.00286	CcSEcCtD
Procaine—Tachycardia—Doxorubicin—muscle cancer	0.00273	0.00285	CcSEcCtD
Procaine—Hyperhidrosis—Doxorubicin—muscle cancer	0.0027	0.00283	CcSEcCtD
Procaine—Hypotension—Doxorubicin—muscle cancer	0.00261	0.00273	CcSEcCtD
Procaine—Urticaria—Methotrexate—muscle cancer	0.00256	0.00268	CcSEcCtD
Procaine—Body temperature increased—Methotrexate—muscle cancer	0.00255	0.00267	CcSEcCtD
Procaine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00255	0.00266	CcSEcCtD
Procaine—Somnolence—Doxorubicin—muscle cancer	0.00249	0.0026	CcSEcCtD
Procaine—Fatigue—Doxorubicin—muscle cancer	0.00241	0.00252	CcSEcCtD
Procaine—Hypersensitivity—Methotrexate—muscle cancer	0.00238	0.00249	CcSEcCtD
Procaine—Pruritus—Methotrexate—muscle cancer	0.00228	0.00239	CcSEcCtD
Procaine—Urticaria—Doxorubicin—muscle cancer	0.00222	0.00232	CcSEcCtD
Procaine—Body temperature increased—Doxorubicin—muscle cancer	0.00221	0.00231	CcSEcCtD
Procaine—Diarrhoea—Methotrexate—muscle cancer	0.00221	0.00231	CcSEcCtD
Procaine—Dizziness—Methotrexate—muscle cancer	0.00213	0.00223	CcSEcCtD
Procaine—SCN10A—head—muscle cancer	0.00213	0.0487	CbGeAlD
Procaine—Hypersensitivity—Doxorubicin—muscle cancer	0.00206	0.00215	CcSEcCtD
Procaine—Vomiting—Methotrexate—muscle cancer	0.00205	0.00215	CcSEcCtD
Procaine—Rash—Methotrexate—muscle cancer	0.00204	0.00213	CcSEcCtD
Procaine—Dermatitis—Methotrexate—muscle cancer	0.00203	0.00213	CcSEcCtD
Procaine—Pruritus—Doxorubicin—muscle cancer	0.00198	0.00207	CcSEcCtD
Procaine—HTR3A—head—muscle cancer	0.00197	0.0451	CbGeAlD
Procaine—Nausea—Methotrexate—muscle cancer	0.00192	0.00201	CcSEcCtD
Procaine—Diarrhoea—Doxorubicin—muscle cancer	0.00191	0.002	CcSEcCtD
Procaine—Dizziness—Doxorubicin—muscle cancer	0.00185	0.00193	CcSEcCtD
Procaine—Vomiting—Doxorubicin—muscle cancer	0.00178	0.00186	CcSEcCtD
Procaine—Rash—Doxorubicin—muscle cancer	0.00176	0.00184	CcSEcCtD
Procaine—Dermatitis—Doxorubicin—muscle cancer	0.00176	0.00184	CcSEcCtD
Procaine—BCHE—smooth muscle tissue—muscle cancer	0.0017	0.0389	CbGeAlD
Procaine—Nausea—Doxorubicin—muscle cancer	0.00166	0.00174	CcSEcCtD
Procaine—SLC6A3—head—muscle cancer	0.00164	0.0376	CbGeAlD
Procaine—SLC6A3—testis—muscle cancer	0.00159	0.0363	CbGeAlD
Procaine—BCHE—cardiac atrium—muscle cancer	0.00147	0.0335	CbGeAlD
Procaine—BCHE—bone marrow—muscle cancer	0.00124	0.0283	CbGeAlD
Procaine—BCHE—vagina—muscle cancer	0.00118	0.0271	CbGeAlD
Procaine—BCHE—head—muscle cancer	0.00109	0.025	CbGeAlD
Procaine—BCHE—testis—muscle cancer	0.00106	0.0242	CbGeAlD
